Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17


Impulse Control Disorders and Related Complications of Parkinson's Disease Therapy.

Lopez AM, Weintraub D, Claassen DO.

Semin Neurol. 2017 Apr;37(2):186-192. doi: 10.1055/s-0037-1601887. Epub 2017 May 16.


Parkinson's Impulse-Control Scale for the Severity Rating of Impulse-Control Behaviors in Parkinson's Disease: A Semistructured Clinical Assessment Tool.

Okai D, Askey-Jones S, Mack J, Martin A, Chaudhuri KR, Samuel M, David AS, Brown RG.

Mov Disord Clin Pract. 2016 Sep-Oct;3(5):494-499. Epub 2016 Jan 25.


A survey of impulse control disorders in Parkinson's disease patients in Shanghai area and literature review.

Wang XP, Wei M, Xiao Q.

Transl Neurodegener. 2016 Feb 17;5:4. doi: 10.1186/s40035-016-0051-7. eCollection 2016.


Neuropsychiatric co-morbidities in non-demented Parkinson's disease.

Rai NK, Goyal V, Kumar N, Shukla G, Srivastava AK, Singh S, Behari M.

Ann Indian Acad Neurol. 2015 Jan-Mar;18(1):33-8. doi: 10.4103/0972-2327.144287.


A new nosology of psychosis and the pharmacological basis of affective and negative symptom dimensions in schizophrenia.

Vakalopoulos C.

Ment Illn. 2010 May 6;2(1):e7. doi: 10.4081/mi.2010.e7. eCollection 2010 Jan 25. Review.


Maladaptive reward-learning and impulse control disorders in patients with Parkinson's disease: a clinical overview and pathophysiology update.

Lee JY, Jeon BS.

J Mov Disord. 2014 Oct;7(2):67-76. doi: 10.14802/jmd.14010. Epub 2014 Oct 30. Review.


In a rush to decide: deep brain stimulation and dopamine agonist therapy in Parkinson's disease.

Djamshidian A, O'Sullivan SS, Tomassini A, Foltynie T, Limousin P, Aviles-Olmos I, Warner TT, Lees AJ, Averbeck BB.

J Parkinsons Dis. 2014;4(4):579-83. doi: 10.3233/JPD-140388.


Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.

Connolly B, Fox SH.

Neurotherapeutics. 2014 Jan;11(1):78-91. doi: 10.1007/s13311-013-0238-x. Review.


Diagnosis and treatment of impulse control disorders in patients with movement disorders.

Mestre TA, Strafella AP, Thomsen T, Voon V, Miyasaki J.

Ther Adv Neurol Disord. 2013 May;6(3):175-88. doi: 10.1177/1756285613476127.


Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers.

Okai D, Askey-Jones S, Samuel M, O'Sullivan SS, Chaudhuri KR, Martin A, Mack J, Brown RG, David AS.

Neurology. 2013 Feb 26;80(9):792-9. doi: 10.1212/WNL.0b013e3182840678. Epub 2013 Jan 16.


Decision making, impulsivity, and addictions: do Parkinson's disease patients jump to conclusions?

Djamshidian A, O'Sullivan SS, Sanotsky Y, Sharman S, Matviyenko Y, Foltynie T, Michalczuk R, Aviles-Olmos I, Fedoryshyn L, Doherty KM, Filts Y, Selikhova M, Bowden-Jones H, Joyce E, Lees AJ, Averbeck BB.

Mov Disord. 2012 Aug;27(9):1137-45. doi: 10.1002/mds.25105. Epub 2012 Jul 20.


Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug.

Mizushima J, Takahata K, Kawashima N, Kato M.

Ann Gen Psychiatry. 2012 Jul 7;11(1):19. doi: 10.1186/1744-859X-11-19.


Dopamine agonists and pathologic behaviors.

Kelley BJ, Duker AP, Chiu P.

Parkinsons Dis. 2012;2012:603631. doi: 10.1155/2012/603631. Epub 2012 Apr 5.


Novelty seeking behaviour in Parkinson's disease.

Djamshidian A, O'Sullivan SS, Wittmann BC, Lees AJ, Averbeck BB.

Neuropsychologia. 2011 Jul;49(9):2483-8. doi: 10.1016/j.neuropsychologia.2011.04.026. Epub 2011 May 4.


Altruistic punishment in patients with Parkinson's disease with and without impulsive behaviour.

Djamshidian A, O'Sullivan SS, Doherty K, Lees AJ, Averbeck BB.

Neuropsychologia. 2011 Jan;49(1):103-7. doi: 10.1016/j.neuropsychologia.2010.10.012. Epub 2010 Oct 19.


Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists.

Bienfait KL, Menza M, Mark MH, Dobkin RD.

J Clin Neurosci. 2010 Apr;17(4):539-40. doi: 10.1016/j.jocn.2009.09.001. Epub 2010 Feb 19.

Supplemental Content

Support Center